Interstitial purine metabolites in hearts with LV remodeling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 2 55-2, 2004, Pages

  Gourine, Andrey V ^a   Hu, Qingsong ^c   Sander, Paul R ^c   Kuzmin, Aleksandr I ^b   Hanafy, Nadia ^c   Davydova, Svetlana A ^b   Zaretsky, Dmitry V ^b   Zhang, Jianyi ^c,d  

^a REPUBLICAN SCIENTIFIC AND PRACTICAL CENTRE CARDIOLOGY   (Belarus)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^c UNIVERSITY OF MINNESOTA   (United States)

^d University of Minnesota   (United States)

Author keywords

ATP; Heart failure; Left ventricle; adrenergic receptors

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE TRIPHOSPHATE; HYPOXANTHINE; INOSINE; ISOPRENALINE; PURINE DERIVATIVE; URIC ACID; XANTHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIALYSATE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE REMODELING; INTERSTITIAL FLUID; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0942287335     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00305.2003     Document Type: Article

References (44)

1. Balaban RS, Kantor HL, Katz LA, and Briggs RW. Relation between work and phosphate metabolite in the in vivo paced mammalian heart. Science 232: 1121-1123, 1986.
2. Bowditch J, Brown AK, and Dow JW. Accumulation and salvage of adenosine and inosine by isolated mature cardiac myocytes. Biochim Biophys Acta 844: 119-128, 1985.
3. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, and Hare JM. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104: 2407-2411, 2001.
4. Ekelund UE, Harrison RW, Shokek O, Thakkar RN, Tunin RS, Senzaki H, Kass DA, Marban E, and Hare JM. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res 85: 437-445, 1999.
5. Ghatak A, Brar MJ, Agarwal A, Goel N, Rastogi AK, Vaish AK, Sircar AR, and Chandra M. Oxy free radical system in heart failure and therapeutic role of oral vitamin E. Int J Cardiol 57: 119-127, 1996.
6. Gustafson LA and Kroll K. Downregulation of 5′-nucleotidase in rabbit heart during coronary underperfusion. Am J Physiol Heart Circ Physiol 274: H529-H538, 1998.
7. Headrick JP. Interstitial adenosine and function in rat heart in vivo: effects of adrenaline and 8-cyclopentyl-1,3-dimethylxanthine. Clin Exp Pharmacol Physiol 23: 386-394, 1996.
8. Headrick JP, Dobson GP, Williams JP, McKirdy JC, Jordan L, and Willis RJ. Bioenergetics and control of oxygen consumption in the in situ rat heart. Am J Physiol Heart Circ Physiol 267: H1074-H1084, 1994.
9. Ingwall JS. Is cardiac failure a consequence of decreased energy reserve? Circulation 87, Suppl VII: VII-58-VII-62, 1993.
10. Jarasch ED, Bruder G, and Heid HW. Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol Scand Suppl 548: 39-46, 1986.
11. Jennings RB, Riemer KA, Hill ML. Total ischemia in dog hearts. Circ Res 49: 901-911, 1981.
12. Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 322: 100-110, 1989.
13. Katz LA, Swain JA, Portman MA, and Balaban RS. Relation between phosphate metabolites and oxygen consumption of heart in vivo. Am J Physiol Heart Circ Physiol 256: H265-H274, 1989.
14. Kroll K, Kinzie DJ, and Gustafson LA. Open-system kinetics of myocardial phosphoenergetics during coronary underperfusion. Am J Physiol Heart Circ Physiol 272: H2563-H2567, 1997.
15. Liu J, Wang C, Murakami Y, Gong G, Ishibashi Y, Prody C, Ochiai K, Bache RJ, Godinot C, and Zhang J. Mitochondrial ATPase and high energy phosphates in failing heart. Am J Physiol Heart Circ Physiol 281: H1319-H1326, 2001.
16. Manfredi JP and Holmes EW. Purine salvage pathways in myocardium. Annu Rev Physiol 47: 691-705, 1985.
17. Massie BM, Schwartz GG, Garcia J, Wisneski JA, Weiner MW, and Twyman O. Myocardial metabolism during increased work states in the porcine left ventricle in vivo. Circ Res 74: 64-73, 1994.
18. Moriwaki Y, Yamamoto T, and Higashino K. Enzymes involved in purine metabolism-a review of histochemical localization and functional implications. Histol Histopathol 14: 1321-1340, 1999.
19. Murakami Y, Zhang Y, Cho YK, Mansoor AM, Chung JK, Chu C, Francis G, Ugurbil K, Bache RJ, From AH, Jerosch-Herold M, Wilke N, and Zhang J. Myocardial oxygenation during high work states in hearts with postinfarction remodeling. Circulation 99: 942-948, 1999.
20. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, and Kochsiek K. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96: 2190-2196, 1997.
21. Neubauer S, Horn M, Naumann A, Tian R, Hu K, Laser M, Friedrich J, Gaudron P, Schnackerz K, and Ingwall JS. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest 95: 1092-1100, 1995.
22. Omerovic E, Bollano E, Basetti M, Kujacic V, Waagstein L, Hjalmarson A, Waagstein F, and Soussi B. Bioenergetic, functional and morphological consequences of postinfarct cardiac remodeling in the rat. J Mol Cell Cardiol 31: 1685-1695, 1999.
23. Pfeffer MA and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172, 1990.
24. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, and Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 44: 503-512, 1979.
25. Pfeffer JM, Pfeffer MA, Fletcher PJ, and Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol Heart Circ Physiol 260: H1406-H1414, 1991.
26. Pfeffer MA, Pfeffer JM, Steinberg C, and Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72: 406-412, 1985.
27. Saupe KW, Spindler M, Tian R, and Ingwall JS. Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ Res 82: 898-907, 1998.
28. Schoutsen B and de Jong JW. Age-dependent increase in xanthine oxidoreductase differs in various heart cell types. Circ Res 61: 604-607, 1987.
29. Schutz W, Schrader J, and Gerlach E. Different sites of adenosine formation in the heart. Am J Physiol Heart Circ Physiol 240: H963-H970, 1981.
30. Skladanowski AC and Newby AC. Partial purification and properties of an AMP-specific soluble 5′-nucleotidase from pigeon heart. Biochem J 268: 117-122, 1990.
31. Shen W, Asai K, Uechi M, Mathier MA, Shannon RP, Vatner SF, and Ingwall JS. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation 100: 2113-2118, 1999.
32. St Cyr JA, Bianco RW, Schneider JR, Mahoney JR Jr, Tveter K, Einzig S, Foker JE. Enhanced high energy phosphate recovery with ribose infusion after global myocardial ischemia in a canine model. J Surg Res 46: 157-162, 1989.
33. 2 in stimulated rat cardiomyocytes. Am J Physiol Heart Circ Physiol 273: H756-H766, 1997.
34. Swain JL, Sabina RL, McHale PA, Greenfield JC Jr, and Holmes EW. Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog. Am J Physiol Heart Circ Physiol 242: H818-H826, 1982.
35. Tian R, Musi N, D'Agostino J, Hirshman MF, and Goodyear LJ. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 104: 1664-1669, 2001.
36. Van Wylen DG, Willis J, Sodhi J, Weiss RJ, Lasley RD, and Mentzer RM Jr. Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow. Am J Physiol Heart Circ Physiol 258: H1642-H1649, 1990.
37. Waller C, Hiller KH, Kahler E, Hu K, Nahrendorf M, Voll S, Haase A, Ertl G, and Bauer WR. Serial magnetic resonance imaging of microvascular remodeling in the infarcted rat heart. Circulation 103: 1564-1569, 2001.
38. Ye Y, Gong G, Ochiai K, Liu J, and Zhang J. High-energy phosphate metabolism and creatine kinase in failing hearts. Circulation 103: 1570-1576, 2001.
39. 31P NMR study. Am J Physiol Heart Circ Physiol 268: H1891-H1905, 1995.
40. Zhang J and McDonald K. Bioenergetic consequence of left ventricular remodeling secondary to discrete myocardial infarction. Circulation 92: 1011-1019, 1995.
41. Zhang J, Merkle H, Hendrich K, Garwood M, From AH, Ugurbil K, and Bache RJ. Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest 92: 993-1003, 1993.
42. Zhang J, Toher C, Zhang Y, Ugurbil K, Bache RJ, and Homans D. Bioenergetic consequences of volume overloaded hypertrophy. Circulation 96: 334-343, 1997.
43. Zhang J, Murakami Y, Zhang Y, Cho YK, Ye Y, Gong G, Bache RJ, Ugurbil K, and From AHL. Oxygen delivery does not limit cardiac performance during high work states. Am J Physiol Heart Circ Physiol 276: H50-H57, 1999.
44. 31P-MRS study., Circulation 94: 1089-1100, 1996.